FIELD: medicine. SUBSTANCE: method involves the successive topical use of sorbent SUMS-1 containing immobilized immozymase, metronidazole and xenolymphocytes suspension. Method ensures to limit infectious process spreading, prevent the combination with the second infection and decrease percent of suppurative-septic complications by correction of topical and total immunity and inhibition of pathological microflora. EFFECT: enhanced effectiveness of method.
Authors
Dates
2000-01-20—Published
1996-11-26—Filed